Glycotest
Glycotest Inc.
Glycotest Diagnostics – Developing unique and non-invasive blood tests for liver cancers and fibrosis-cirrhosis. Our technology could revolutionize care and treatment for people at risk due to chronic
glycotest.com · Merion Station, PA
Funding event
The round itself, as filedInferred stageSeed
Sold of offered$3.2M of $6.8M
Filed2026-07-16
Days since filing80
- Exemption claimed
- Rule 506(b)
- First-ever Form D
- Yes
- Date of first sale
- 2026-06-30
Investors
No investors named: Form D does not list them
Officers on the filing
Names and roles as filed; addresses are never stored- Charles SwindellExecutive Officer · Director
- Ilian IlievDirector
- Ed HooperDirector
- Jenny JiangDirector
Health flags
Three flags, each with the raw inputs behind it · as of 2026-10-03UndersubscribedFlagged47.4% sold3.1 months since first sale
Prior raiseNot flaggedPrior raise not known—
AmendedNot flaggedNo amendmentNo D/A on file
Open roles
On the employer's own careers page · checked 2026-09-240
Pre-posting windowNot enough dataShown once this sector and stage have 20 observed lags from filing to first posting.
No open roles foundWe read careers pages daily.